Larimar Therapeutics, Inc. (LRMR)
USD 4.16
(-3.7%)
USD 4.16
(-3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 311 Thousand | 272 Thousand | 326 Thousand | 155 Thousand | 78 Thousand | 261 Thousand |
| Gross Profit | -311 Thousand | -272 Thousand | -326 Thousand | -155 Thousand | -78 Thousand | -261 Thousand |
| Operating Expenses | 41.75 Million | 36.52 Million | 50.46 Million | 42.8 Million | 23.21 Million | 62.46 Million |
| Selling, General and Administrative Expenses | 14.08 Million | 12.27 Million | 12.06 Million | 11.39 Million | 2.42 Million | 12.93 Million |
| Research and Development Expenses | 27.35 Million | 24.25 Million | 38.39 Million | 31.4 Million | 20.79 Million | 49.52 Million |
| Other Expenses | - | 1.17 Million | -171 Thousand | 322 Thousand | 82 Thousand | - |
| Cost and Expenses | 41.75 Million | 36.52 Million | 50.46 Million | 42.8 Million | 23.21 Million | 62.72 Million |
| Operating Income | -41.75 Million | -36.52 Million | -50.46 Million | -42.8 Million | -23.21 Million | -62.72 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -1.17 Million | -326 Thousand | -155 Thousand | -93.86 Thousand | -1.6 Million |
| Earnings before Tax | -36.94 Million | -35.35 Million | -50.63 Million | -42.48 Million | -23.13 Million | -62.96 Million |
| Net Income | -36.94 Million | -34.18 Million | -50.31 Million | -42.32 Million | -23.13 Million | -61.36 Million |
| Earnings Per Share Basic | -0.84 | -1.33 | -2.93 | -3.56 | -2.51 | -22.85 |
| Earnings Per Share Diluted | -0.84 | -1.33 | -2.93 | -3.56 | -2.51 | -22.85 |
| Weighted Average Shares Outstanding | 43.9 Million | 25.76 Million | 17.16 Million | 11.88 Million | 9.21 Million | 2.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.9 Million | 25.76 Million | 17.16 Million | 11.88 Million | 9.21 Million | 2.68 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -41.44 Million | -35.08 Million | -50.13 Million | -42.64 Million | -23.13 Million | -60.8 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 74 Thousand | 87 Thousand | 80 Thousand | 81 Thousand | 311 Thousand | 69 Thousand |
| Gross Profit | -74 Thousand | -87 Thousand | -80 Thousand | -81 Thousand | -311 Thousand | -69 Thousand |
| Operating Expenses | 18.26 Million | 24.51 Million | 16.65 Million | 14.08 Million | 41.44 Million | 10.33 Million |
| Selling, General and Administrative Expenses | 4.34 Million | 4.91 Million | 3.79 Million | 3.51 Million | - | 3.75 Million |
| Research and Development Expenses | 13.91 Million | 19.59 Million | 12.85 Million | 10.56 Million | - | 6.58 Million |
| Other Expenses | - | 2.97 Million | 2.08 Million | 1.16 Million | - | 1.27 Million |
| Cost and Expenses | 18.26 Million | 24.59 Million | 16.73 Million | 14.16 Million | 41.75 Million | 10.33 Million |
| Operating Income | -18.26 Million | -24.59 Million | -16.73 Million | -14.16 Million | -41.75 Million | -10.33 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -74 Thousand | - | 36.72 Thousand | 37.18 Thousand | - | -76 Thousand |
| Earnings before Tax | -15.49 Million | -21.62 Million | -14.65 Million | -12.99 Million | -36.94 Million | -9.06 Million |
| Net Income | -15.49 Million | -21.62 Million | -14.65 Million | -12.99 Million | -36.94 Million | -9.06 Million |
| Earnings Per Share Basic | -0.24 | -0.34 | -0.27 | -0.30 | - | -0.21 |
| Earnings Per Share Diluted | -0.24 | -0.34 | -0.27 | -0.30 | - | -0.21 |
| Weighted Average Shares Outstanding | 63.8 Million | 63.8 Million | 53.55 Million | 43.9 Million | 43.9 Million | 43.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.8 Million | 63.8 Million | 53.55 Million | 43.9 Million | 43.9 Million | 43.9 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -18.26 Million | -24.51 Million | -16.65 Million | -14.08 Million | - | -10.33 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
3808
7444
BAK
NDSN
RGP
ECPG